MedTrace Logo

South Asian HeArt Risk Assessment Project - Trial (SAHARA-Trial)

NCT01841398 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 343

Last updated 2016-06-09

No results posted yet for this study

Summary

People who originate from the Indian subcontinent known as South Asians are the fastest growing group of non-white Canadians. They suffer an excess prevalence of abdominal obesity, type 2 diabetes and heart disease. They also develop these risk factors at significantly lower body weight and at younger ages compared to people of European origin. The purpose of SAHARA (South Asian HeArt Risk Assessment) Trial, is to recruit 330 South Asians from Ontario (Principal Investigator: Dr. Sonia Anand) and British Columbia (Co-investigator: Dr. Scott Lear), who use the internet, email and other multimedia devices. Among these participants, the investigators will compare the effectiveness of a 12-month interactive multi-media health behaviour intervention to usual care in reducing cardiac risk factors. This intervention enables participants to set their health goals and provides health messaging and feedback designed to improve their smoking, dietary habits and physical activity. In addition, the investigators will test if knowledge of genetic risk for heart attack influences behaviour change and their heart health risk factor profile. The information generated from SAHARA will enable individuals, physicians, health professionals, and policy makers to develop risk factor modification programs to prevent cardiovascular disease in this high-risk group.

Conditions

Interventions

BEHAVIORAL

Multimedia Lifestyle Improvement

* Goal setting to improve diet, physical activity or smoking behaviours * Regular health messaging related to the participant's goal, sent by email or text messaging, based on participant preference.

BEHAVIORAL

Usual Care

Participant will be refered to SAHARA study website to get information on healthy lifestyle and to get regular update for the course of follow-up.

Sponsors & Collaborators

Principal Investigators

  • Sonia Anand, MD, PhD · McMaster University; Hamilton Health Sciences; Population Health Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2014-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01841398 on ClinicalTrials.gov